Fact CheckerSign in

NCT06915116RecruitingPhase 2

Acupuncture for People Experiencing Period Loss Due to Chemotherapy

Acupuncture for Adolescent and Young Adult Cancer Patients: (AcuAYA)

Source: ClinicalTrials.gov · Last updated 17 Aug 2026

Brief summary (registry, in English)

The purpose of this study is to find out whether it is practical (feasible) to use acupuncture to treat period loss (amenorrhea) caused by chemotherapy treatment in people with cancer. The researchers will look at how many participants enroll and complete the study. The researchers will also study how treatment with acupuncture affects the amount of time for the menstrual cycle to return and symptoms and quality of life related to amenorrhea.

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
60 (estimated)
First submitted
1 Apr 2025
Start date
31 Mar 2025
Primary completion date
31 Mar 2027
Lead sponsor
Memorial Sloan Kettering Cancer Center
NCT number
NCT06915116

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 60
  • From 31 Mar 2025 to the primary completion date, 31 Mar 2027
  • 7 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Had been pregnant or lactating within 3 months prior to enrollment
  • Ongoing or planned radiation or surgery within 4 months from randomization
  • Had been or will be receiving ovarian suppression medicine, such as leuprolide (Lupron) and goserelin (Zoladex), or hormonal contraception drugs within 3 months of enrollment or during the study period

Other illness

  • History of hysterectomy or bilateral oophorectomy

Other

  • Use of acupuncture for menses recovery within 3 months of enrollment

Who the study is looking for

  • English speaking woman between the ages of 15 and 40
  • History of stage I, II, or III cancer OR stage IV or unstaged hematologic malignancy (e.g. lymphoma, leukemia, myeloma) that is stable, as assessed by care team
  • Premenopausal status with regular menstruation at the time of diagnosis by patient report
  • Completed cytotoxic chemotherapy within the past year
  • Premenopausal status with regular menstruation at the time of diagnosis by patient report for females ages 18 or older
  • Report cessation of menses during or after chemotherapy and have not experienced menses recovery at the time of enrollment.
  • Have reached menarche prior to therapy or during therapy for females between 15 and 17 years old
  • Patient meets at least one of the following:
  • Reports cessation of menses during or after chemotherapy and have not experienced menses recovery at the time of enrollment and has been without menses for at least 3 months 64 following the completion of cytotoxic chemotherapy; OR
  • Is receiving ovarian suppression therapy (e.g., leuprolide \[Lupron\] or goserelin \[Zoladex\]) or hormonal contraceptive drugs, regardless of menstrual status, and report persistent (≥3 months), moderate-to- severe menopause-related symptoms, defined as a score of ≥4 on a 0-10 scale for at least one MENQOL item during eligibility screening.
  • Willing to adhere to all study-related procedures, including randomization to one of the two possible arms: acupuncture and WLC

Age in the registry: 15 years to 40 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (7)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Coordinator of this site? Confirm its status
Basking RidgeUnited StatesRecruiting
Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
Coordinator of this site? Confirm its status
CommackUnited StatesRecruiting
Memorial Sloan Kettering Westchester (All Protocol Activities)
Coordinator of this site? Confirm its status
East White PlainsUnited StatesRecruiting
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Coordinator of this site? Confirm its status
MiddletownUnited StatesRecruiting
Memorial Sloan Kettering Bergen (All Protocol Activities)
Coordinator of this site? Confirm its status
MontvaleUnited StatesRecruiting
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting
Memorial Sloan Kettering Nassau (All Protocol Activities)
Coordinator of this site? Confirm its status
Rockville CentreUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.